BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12788654)

  • 1. Inhibiting AIDS in the central nervous system: gene delivery to protect neurons from HIV.
    Cordelier P; Van Bockstaele E; Calarota SA; Strayer DS
    Mol Ther; 2003 Jun; 7(6):801-10. PubMed ID: 12788654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir.
    Mukhtar M; Duke H; BouHamdan M; Pomerantz RJ
    Hum Gene Ther; 2000 Jan; 11(2):347-59. PubMed ID: 10680847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant enzyme gene delivery to protect from HIV-1 gp120-induced neuronal apoptosis.
    Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2006 Dec; 13(23):1645-56. PubMed ID: 16871233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using gene delivery to protect HIV-susceptible CNS cells: inhibiting HIV replication in microglia.
    Cordelier P; Strayer DS
    Virus Res; 2006 Jun; 118(1-2):87-97. PubMed ID: 16414141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective lentiviral vectors are efficiently trafficked by HIV-1 and inhibit its replication.
    Klimatcheva E; Planelles V; Day SL; Fulreader F; Renda MJ; Rosenblatt J
    Mol Ther; 2001 Jun; 3(6):928-39. PubMed ID: 11407907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS.
    Plavec I; Agarwal M; Ho KE; Pineda M; Auten J; Baker J; Matsuzaki H; Escaich S; Bonyhadi M; Böhnlein E
    Gene Ther; 1997 Feb; 4(2):128-39. PubMed ID: 9081703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication.
    Bonyhadi ML; Moss K; Voytovich A; Auten J; Kalfoglou C; Plavec I; Forestell S; Su L; Böhnlein E; Kaneshima H
    J Virol; 1997 Jun; 71(6):4707-16. PubMed ID: 9151864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative Rev trans-activator.
    Bevec D; Dobrovnik M; Hauber J; Böhnlein E
    Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9870-4. PubMed ID: 1409715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication.
    Bahner I; Sumiyoshi T; Kagoda M; Swartout R; Peterson D; Pepper K; Dorey F; Reiser J; Kohn DB
    Mol Ther; 2007 Jan; 15(1):76-85. PubMed ID: 17164778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of HIV-1 in the central nervous system by IFN-alpha2 delivered by an SV40 vector.
    Cordelier P; Calarota SA; Pomerantz RJ; Xiaoshan J; Strayer DS
    J Interferon Cytokine Res; 2003 Sep; 23(9):477-88. PubMed ID: 14565857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human immunodeficiency virus-1 production resulting from transduction with a retrovirus containing an HIV-regulated diphtheria toxin A chain gene.
    Harrison GS; Long CJ; Curiel TJ; Maxwell F; Maxwell IH
    Hum Gene Ther; 1992 Oct; 3(5):461-9. PubMed ID: 1329991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SV40-derived vectors provide effective transgene expression and inhibition of HIV-1 using constitutive, conditional,and pol III promoters.
    Jayan GC; Cordelier P; Patel C; BouHamdan M; Johnson RP; Lisziewicz J; Pomerantz RJ; Strayer DS
    Gene Ther; 2001 Jul; 8(13):1033-42. PubMed ID: 11438838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by HIV-1-based lentivirus vectors expressing transdominant Rev.
    Mautino MR; Keiser N; Morgan RA
    J Virol; 2001 Apr; 75(8):3590-9. PubMed ID: 11264348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Foamy virus vectors expressing anti-HIV transgenes efficiently block HIV-1 replication.
    Taylor JA; Vojtech L; Bahner I; Kohn DB; Laer DV; Russell DW; Richard RE
    Mol Ther; 2008 Jan; 16(1):46-51. PubMed ID: 17955023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient gene transfer to hematopoietic progenitor cells using SV40-derived vectors.
    Strayer DS; Pomerantz RJ; Yu M; Rosenzweig M; BouHamdan M; Yurasov S; Johnson RP; Goldstein H
    Gene Ther; 2000 May; 7(10):886-95. PubMed ID: 10845727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV-1 proprotein processing as a target for gene therapy.
    Cordelier P; Zern MA; Strayer DS
    Gene Ther; 2003 Mar; 10(6):467-77. PubMed ID: 12621451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for CNS-directed gene delivery: in vivo gene transfer to the brain using SV40-derived vectors.
    Louboutin JP; Reyes BA; Agrawal L; Van Bockstaele E; Strayer DS
    Gene Ther; 2007 Jun; 14(12):939-49. PubMed ID: 17443215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell-based gene therapy for acquired immunodeficiency syndrome: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro.
    Su L; Lee R; Bonyhadi M; Matsuzaki H; Forestell S; Escaich S; Böhnlein E; Kaneshima H
    Blood; 1997 Apr; 89(7):2283-90. PubMed ID: 9116270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rat model of human immunodeficiency virus 1 encephalopathy using envelope glycoprotein gp120 expression delivered by SV40 vectors.
    Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
    J Neuropathol Exp Neurol; 2009 May; 68(5):456-73. PubMed ID: 19525894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.